End‐stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection
- 16 January 2012
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 19 (5) , 371-376
Abstract
Summary. Recipients of haemodialysis for end‐stage renal disease (ESRD) have a higher prevalence of hepatitis C virus (HCV) infection relative to the general US population. However, the natural course of HCV infection in patients with renal failure, including African Americans (AAs) and Caucasian Americans (CAs), is not well known. We compared the degree of liver inflammation and fibrosis in AA and CA patients with HCV infection, with and without ESRD. This was a cross‐sectional study of 156 HCV patients with ESRD (130 AAs and 26 CAs) with a liver biopsy between 1992 and 2005. The control group consisted of 138 patients (50 AAs; 88 CAs) with HCV infections and a serum creatinine P < 0.0001) and less hepatic necro‐inflammation (Knodell histological activity index ‐I, II and III; P < 0.05) and fibrosis (Knodell histological activity index ‐IV; P < 0.0001). There were no racial differences in serum liver chemistry and histology scores among patients with renal failure. In a multivariate analysis, younger age, ESRD, AA race and a lower serum alkaline phosphatase were associated with lower odds for advanced liver fibrosis. Thus, HCV patients with ESRD had a lower degree of hepatic inflammation and fibrosis compared to those without renal disease, independent of race.Keywords
This publication has 25 references indexed in Scilit:
- Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection†‡Hepatology, 2006
- Hepatitis C Infection in Hemodialysis Patients: Protective Against Oxidative Stress?Transplantation Proceedings, 2006
- Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPSKidney International, 2004
- Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy studyGut, 2004
- Hepatitis C infection and the patient with end-stage renal diseaseHepatology, 2002
- HISTOPATHOLOGICAL FEATURES OF HEPATITIS C IN RENAL TRANSPLANT CANDIDATES1Transplantation, 2000
- Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factorKidney International, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Effect of hepatitis C infection and renal transplantation on survival in end-stage renal diseaseKidney International, 1998
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981